Growth Metrics

Acadia Pharmaceuticals (ACAD) Net Margin (2010 - 2026)

Acadia Pharmaceuticals' quarterly Net Margin came in at 1.36% in Q1 2026, down 641.0% year-on-year from 0.25% in Q1 2025, and down 98.59% quarter-over-quarter from 96.33% in Q4 2025.

Acadia Pharmaceuticals has reported Net Margin for 17 years, with the latest figure at 1.36% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 641.0% year-over-year to 1.36%; the trailing twelve-month figure through Mar 2026 stood at 34.3% (up 1132.0% YoY), and the FY2025 full-year result was 36.49%, up 1285.0% from the prior year.
  • Net Margin for Q1 2026 stood at 1.36%, down from 96.33% in the prior quarter.
  • The five-year high for Net Margin was 96.33% in Q4 2025, with the low at 97.91% in Q1 2022.
  • Average Net Margin over 5 years is 0.62%, with a median of 7.77% recorded in 2025.
  • Year-over-year, Net Margin plunged 3555 bps in 2022 and soared 6159 bps in 2023.
  • Tracing ACAD's Net Margin over 5 years: stood at 30.53% in 2022, then soared by 165 bps to 19.82% in 2023, then jumped by 179 bps to 55.37% in 2024, then jumped by 74 bps to 96.33% in 2025, then tumbled by 99 bps to 1.36% in 2026.
  • The last three Net Margin figures came in at 1.36% (Q1 2026), 96.33% (Q4 2025), and 25.76% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn 1.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.36%
Dec 31, 2025 96.33%
Sep 30, 2025 25.76%
Jun 30, 2025 10.08%
Mar 31, 2025 7.77%
Dec 31, 2024 55.37%
Sep 30, 2024 13.09%
Jun 30, 2024 13.80%
Mar 31, 2024 8.04%
Dec 31, 2023 19.82%
Sep 30, 2023 -30.79%
Jun 30, 2023 0.67%
Mar 31, 2023 -36.32%
Dec 31, 2022 -30.53%
Sep 30, 2022 -20.78%
Jun 30, 2022 -25.24%
Mar 31, 2022 -97.91%
Dec 31, 2021 -32.96%
Sep 30, 2021 -10.98%
Jun 30, 2021 -38.08%
Mar 31, 2021 -62.36%
Dec 31, 2020 -55.00%
Sep 30, 2020 -70.21%
Jun 30, 2020 -38.27%
Mar 31, 2020 -97.73%
Dec 31, 2019 -53.94%
Sep 30, 2019 -44.38%
Jun 30, 2019 -66.03%
Mar 31, 2019 -135.49%
Dec 31, 2018 -110.01%
Sep 30, 2018 -106.57%
Jun 30, 2018 -110.87%
Mar 31, 2018 -111.11%
Dec 31, 2017 -158.06%
Sep 30, 2017 -183.39%
Jun 30, 2017 -221.30%
Mar 31, 2017 -574.66%
Dec 31, 2016 -646.67%
Sep 30, 2016 -1,359.40%
Jun 30, 2016 -73,527.84%
Mar 31, 2016 -1,244,050.00%
Dec 31, 2015 372,700.00%
Sep 30, 2015 -99,758.97%
Jun 30, 2015 -3,937,800.00%
Mar 31, 2015 -1,009,375.00%
Dec 31, 2014 71,112.77%
Sep 30, 2014 -165,240.00%
Jun 30, 2014 -76,767.86%
Mar 31, 2014 -59,426.67%
Dec 31, 2013 36,070.27%
Sep 30, 2013 -4,456.25%
Jun 30, 2013 -2,013.53%
Mar 31, 2013 -1,468.35%
Dec 31, 2012 -1,792.11%
Sep 30, 2012 -69.06%
Jun 30, 2012 -904.67%
Mar 31, 2012 -1,381.78%
Dec 31, 2011 -901.36%
Sep 30, 2011 -869.18%
Jun 30, 2011 -1,425.22%
Mar 31, 2011 -1,340.92%
Dec 31, 2010 83.98%
Sep 30, 2010 -183.70%